Androcur 50 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

androcur 50 mg tabletter

orifarm a/s - cyproteronacetat - tabletter - 50 mg

Androcur 50 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

androcur 50 mg tabletter

2care4 aps - cyproteronacetat - tabletter - 50 mg

Androcur 50 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

androcur 50 mg tabletter

europharma.dk aps - cyproteronacetat - tabletter - 50 mg

Androcur Depot 100 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

androcur depot 100 mg/ml injektionsvæske, opløsning

bayer ab - cyproteronacetat - injektionsvæske, opløsning - 100 mg/ml

Abiraterone Krka Den Europæiske Union - dansk - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Abiraterone Mylan Den Europæiske Union - dansk - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abiraterone acetat - prostatiske neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Accord Den Europæiske Union - dansk - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Feminil mite 2,0+0,035 mg overtrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

feminil mite 2,0+0,035 mg overtrukne tabletter

sandoz a/s - cyproteronacetat, ethinylestradiol - overtrukne tabletter - 2,0+0,035 mg

Akeega Den Europæiske Union - dansk - EMA (European Medicines Agency)

akeega

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplasmer, kastration-resistent - antineoplastiske midler - treatment of adult patients with prostate cancer.

Diane Mite 2,0+0,035 mg overtrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diane mite 2,0+0,035 mg overtrukne tabletter

bayer ab - cyproteronacetat, ethinylestradiol - overtrukne tabletter - 2,0+0,035 mg